Department of Medicine, Division of General Internal Medicine, Duke University School of Medicine, Durham, North Carolina. ORCID: https://orcid.org/0000-0002-1423-003X.
Departments of Medicine and Pediatrics, Division of General Internal Medicine, Duke University School of Medicine, Durham, North Carolina.
J Opioid Manag. 2021 Jan-Feb;17(1):5-7. doi: 10.5055/jom.2021.0608.
The coronavirus disease 2019 (COVID-19) pandemic has had harmful effects on the opioid epidemic. While a negative effect was predicted, we report on this reality in the hospital setting. We have seen a sharp rise in hospitalized patients with opioid use disorder (OUD). Our data should encourage ongoing efforts to reduce barriers in accessing medications for treatment, harm reduction interventions and additional education for trainees, primary care providers, and hospitalists alike. In the current climate, these interventions are critical to save the lives of patients with OUD.
2019 年冠状病毒病（COVID-19）大流行对阿片类药物流行产生了有害影响。虽然预计会产生负面影响，但我们在医院环境中报告了这一现实。我们看到患有阿片类药物使用障碍（OUD）的住院患者急剧增加。我们的数据应鼓励继续努力，减少获取治疗药物、减少伤害干预措施以及为受训人员、初级保健提供者和医院医生提供更多教育方面的障碍。在当前情况下，这些干预措施对于挽救 OUD 患者的生命至关重要。
